Side-effect deep dive

Fatigue + low energy on GLP-1 medications

Common in early titration from reduced calorie + carb intake. Persistent fatigue past week 8 warrants thyroid, ferritin, B12 labs.

Why it happens

Rapid drop in calorie + carbohydrate intake during titration produces a transient low-energy state similar to mild starvation. Most patients adapt by week 6-8 at stable dose. Persistent fatigue past that window suggests nutritional deficiency or thyroid issue rather than GLP-1.

How to manage it

  1. 1.Adequate protein intake (1.2-1.6 g/kg ideal body weight)
  2. 2.Iron-rich foods or supplement if labs show low ferritin
  3. 3.Hydration β‰₯80 oz/day (mild dehydration mimics fatigue)
  4. 4.Avoid aggressive calorie deficits β€” eat at least 1,200-1,400 cal/day
  5. 5.Get B12 + thyroid panel if fatigue persists past week 8

When to call your prescriber

  • Persistent severe fatigue past week 8 at stable dose
  • Fatigue with depression symptoms
  • Orthostatic dizziness (rapid weight loss + dehydration)

Affected medications

Sources

People also ask

Common questions readers ask

Does Ozempic cause hair loss?
Not directly. Hair shedding (telogen effluvium) is reported by some patients ~3 months into rapid weight loss β€” typical of any rapid-weight-loss state, not unique to GLP-1.
Full evidence-graded answer
What foods should you avoid on a GLP-1?
Avoid greasy, fried, and ultra-processed foods (worst nausea), high-sugar drinks (rapid reflux), and large portions of red meat or cruciferous vegetables (slow gastric emptying compounds GI side effects). Adequate protein + soluble fiber + hydration are the wins.
Full evidence-graded answer
How long do GLP-1 side effects last?
Most GI side effects (nausea, constipation, reflux) peak in weeks 1-2 after each dose increase and resolve within 4 weeks. If you stay on a stable dose without further titration, side effects typically fade for β‰₯80% of patients by week 12.
Full evidence-graded answer
Does Ozempic cause stomach paralysis (gastroparesis)?
GLP-1 medications delay gastric emptying as part of their mechanism β€” that is not stomach paralysis. True gastroparesis after GLP-1 use is rare and the absolute risk in pharmacovigilance data is small. Symptoms (severe nausea, vomiting, abdominal pain past week 8) warrant evaluation.
Full evidence-graded answer

Editorial information based on FDA-label prevalence data + AERS pharmacovigilance + patient-reported outcome corpora. Not personal medical advice.